Zvi Mowshowitz joins Prakash Narayanan and Nathan Labenz to examine Dario Amodei’s case for slowing AI, frontier pacing, bio risk, China, and regulation.
EPISODE 2026-09-14
Dario, AI Doomerism, and Regulation
Zvi Mowshowitz joins AI:AM to discuss Dario Amodei, AI doomerism, regulation, bio risk, China, and frontier model pacing.
The rundown
- 5:01Interview118 minZvi Mowshowitz
Zvi MowshowitzShould AI labs slow down? This conversation examines AI safety, recursive self-improvement, bio risk, China’s AI race, and the case for pacing frontier models. Zvi Mowshowitz and the hosts debate physical bottlenecks, AI regulation, open-source safeguards, Anthropic’s IPO, and how to earn public trust before capabilities outrun oversight.Watch
Clips
AI Biology Enters The Danger Zone
0:00 / 0:00Safety Warnings Are Bad IPO Marketing
0:00 / 0:00A Hard Takeoff Could Arrive Within A Year
0:00 / 0:00The Product Liability Argument Fails
0:00 / 0:00The Problem Is Losing To China
0:00 / 0:00
In this episode
Zvi Mowshowitz joins Prakash Narayanan and Nathan Labenz for a discussion of Dario Amodei’s warning about AI progress outrunning oversight. The episode covers AI doomerism, frontier pacing, bio risk, lab bottlenecks, the China race, Anthropic’s incentives, public trust, and what regulation or compromise could realistically look like.
- Should AI labs slow down? This conversation examines AI safety, recursive self-improvement, bio risk, China’s AI race, and the case for pacing frontier models. Zvi Mowshowitz and the hosts debate physical bottlenecks, AI regulation, open-source safeguards, Anthropic’s IPO, and how to earn public trust before capabilities outrun oversight.